June 8, 2017 / 10:12 AM / a month ago

BRIEF-SciClone Pharmaceuticals to be acquired by Consortium Led by GL Capital

1 Min Read

June 8 (Reuters) - Sciclone Pharmaceuticals Inc

* Sciclone Pharmaceuticals Inc says deal for $11.18 per share Sciclone enters into definitive merger agreement to be acquired by consortium led by GL capital

* Sciclone pharmaceuticals inc says deal for ‍approximately $605 million​

* Transaction, which was unanimously approved by Sciclone's board, values company at approximately $605 million

* Transaction will be funded by buyer consortium through a combination of equity financing

* Says lazard is serving as exclusive financial advisor to Sciclone and Dla Piper LLP (us) is serving as its legal advisor

* Transaction was unanimously approved by Sciclone's board

* Transaction will also be funded by consortium through debt financing, and is not subject to a financing condition Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below